RFL

Rafael Holdings, Inc.

Pharmaceutical Preparations · SIC 2834CIK 1713863Held by 1 tracked managerEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

Revenue FY2025

$0.0M

Net Income FY2025

$(31.0M)

EPS (Basic, as reported)

$-1.04

Net Margin FY2025

-101733.3%

ROE FY2025

-32.3%

Total Equity

$94.0M

Shares Out

Business description

Rafael Holdings, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2016–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions

default rows · click any row to chart itRevenue: 6 → 0

Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025

Revenue6645540010

Cost of revenue—————(3)(3)—0—

Research & development——(1)(1)(2)(5)(9)(6)(4)(13)

Selling, general & administrative(3)(4)(6)(9)(9)(20)(17)———

General & administrative—————(6)(17)(9)(9)(14)

Operating income10(4)(7)(8)(30)(60)(15)(103)(29)

Interest expense———0000—0(1)

Other income (expense), net————————00

Pre-tax income10(4)(5)(7)(25)(140)(9)(67)(33)

Income tax expense00(8)000—0(3)(3)

Net income10(12)(5)(10)(25)(141)(2)(34)(31)

EPS — basic$0.06$0.01($0.93)——($1.49)($6.31)($0.08)($1.45)($1.04)

EPS — diluted$0.06$0.01($0.93)——($1.49)($6.31)($0.08)($1.45)($1.04)

Shares outstanding — basic (M)000——1720232429

Shares outstanding — diluted (M)000——1720232429

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.